This content is machine translated The Anemic Elderly Patient in Family Practice What should be considered? The incidence of anemia increases with age and cannot be considered a normal physiological sign of aging. In persons over 65 years of age, the prevalence of anemia ranges from…
View Post 2 min This content is machine translated Lymphoma as a result of breast implants Beauty at what price? A potentially new subcategory of anaplastic large cell lymphoma shows an association with breast implants. Researchers have compiled evidence from the 71 cases published to date. The main characteristics of…
View Post 4 min This content is machine translated Acute myeloid leukemia Treatment options for non-intensively treatable patients. At the EHA Congress in Milan, experts discussed treatment options for patients with acute myeloid leukemia. Elderly patients in particular continue to have a poor prognosis under intensive chemotherapy. Allogeneic…
View Post 6 min This content is machine translated Congenital immunodeficiencies What warning signs should you be aware of? A functioning immune system is vital. In congenital and acquired immunodeficiencies, part of the immune system does not function or is completely absent. Congenital immunodeficiencies are rare. About one in…
View Post 5 min This content is machine translated Myeloproliferative neoplasms Where is the journey going? Classic myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Several sessions at the EHA Congress in mid-June addressed the revision in the guidelines, news on JAK inhibition,…
View Post 3 min This content is machine translated Hodgkin's lymphoma Does brentuximab vedotin have curative potential in a subset of affected individuals? New results from a phase II study presented at the ASH Congress in New Orleans offer hope for patients with refractory or relapsed Hodgkin’s lymphoma: Approximately 10% of participants in…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia Not only ibrutinib attracts attention For patients with refractory or relapsed chronic lymphocytic leukemia, several agents are currently under investigation that show promising results. At the EHA Congress in Milan, the main focus was on…
View Post 5 min This content is machine translated Myeloproliferative neoplasms News from a field that is developing rapidly Classic myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Several sessions at the EHA Congress in mid-June addressed the revision in the guidelines, news on JAK inhibition,…
View Post 4 min This content is machine translated Hemato-Oncology All hopes lie in targeted therapy What do so-called targeted therapies actually aim at? And what progress has been made in the various hematologic oncologic neoplasms in this regard? At the 21st Symposium Medicine in the…
View Post 4 min This content is machine translated Multiple Myeloma Active ingredients at a glance At the EHA Congress in Milan, multiple myeloma was the focus of several events. What are the current results of proteasome inhibitors and immunomodulatory drugs and what is their promise…
View Post 3 min This content is machine translated Amyloidoses Heart complaints can give first indication In the field of rare diseases, there is an enormous need to catch up in terms of knowledge, correct diagnosis and therapy. Many primary care physicians are also feeling this…
